Researchers find new mechanism to turn on cancer-killing T cells
A new mechanism involved in the anti-cancer immune response has been identified and may have implications for targeting antigens.
ASCO Annual Meeting returns to Chicago, celebrates new progress in cancer
Oncology professionals from around the world shared the latest clinical cancer advances in every area of cancer research at the American Society of Clinical Oncology Annual Meeting.
Researchers uncover inhibitory role of ‘Ter cells’ in cancer therapies
Results identify multiple targets to potentially improve outcomes after radiotherapy and immunotherapy.